4//SEC Filing
Wasoff Evan L 4
Accession 0001214659-22-012390
CIK 0001625288other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 11:04 AM ET
Size
8.5 KB
Accession
0001214659-22-012390
Insider Transaction Report
Form 4
Wasoff Evan L
Chief Financial Officer
Transactions
- Award
Common stock
2022-10-17+250,000→ 3,500,000 total
Holdings
- 1,500,000
Options to purchase common stock (right to buy)
Exercise: $0.08From: 2020-08-19Exp: 2027-08-19→ common stock (1,500,000 underlying) - 420,000
Options to purchase common stock (right to buy)
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ common stock (420,000 underlying) - 200,000
Options to purchase common stock (right to buy)
Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ common stock (200,000 underlying)
Footnotes (1)
- [F1]Issued in lieu of compensation for services.
Documents
Issuer
NEXIEN BIOPHARMA, INC.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001719738
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 11:04 AM ET
- Size
- 8.5 KB